| Image |
No pdb structure |
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
- N,N-dimethylformamide
- Cumidine
- Mdl 101,146
- 2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide
- N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide
- N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide
- N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide
- Freselestat
- (3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid
- (TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE
- (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE
- [1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER
- METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE
- (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID
- 3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE
- (2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID
- (2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID
|
| Diseases |
|
| GWAS |
|
| Interacting Genes |
8 interacting genes:
A2M
CDK2
CSN2
ERBB3
LPA
PI3
SERPINA1
SERPINA3
|
| Entrez ID |
1990 |
| HPRD ID |
00553 |
| Ensembl ID |
ENSG00000139610
|
| Uniprot IDs |
Q9UNI1
|
| PDB IDs |
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|